These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 36512367)

  • 1. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
    Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
    JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement.
    Kahan BC; Hall SS; Beller EM; Birchenall M; Elbourne D; Juszczak E; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Chan AW; Montgomery AA
    JAMA Netw Open; 2023 Dec; 6(12):e2346121. PubMed ID: 38051535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.
    Butcher NJ; Mew EJ; Monsour A; Chan AW; Moher D; Offringa M
    Trials; 2020 Jul; 21(1):620. PubMed ID: 32641085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
    Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
    Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ;
    Lancet Digit Health; 2020 Oct; 2(10):e549-e560. PubMed ID: 33328049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension.
    Rivera SC; Liu X; Chan AW; Denniston AK; Calvert MJ;
    BMJ; 2020 Sep; 370():m3210. PubMed ID: 32907797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ; ; ;
    Nat Med; 2020 Sep; 26(9):1351-1363. PubMed ID: 32908284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.
    Kahan BC; Hall SS; Beller EM; Birchenall M; Chan AW; Elbourne D; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Juszczak E; Montgomery AA
    JAMA; 2023 Dec; 330(21):2106-2114. PubMed ID: 38051324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.
    Kendall TJ; Robinson M; Brierley DJ; Lim SJ; O'Connor DJ; Shaaban AM; Lewis I; Chan AW; Harrison DJ;
    Lancet Oncol; 2021 Oct; 22(10):e435-e445. PubMed ID: 34592193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
    Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
    Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.
    Solovyeva O; Dimairo M; Weir CJ; Hee SW; Espinasse A; Ursino M; Patel D; Kightley A; Hughes S; Jaki T; Mander A; Evans TRJ; Lee S; Hopewell S; Rantell KR; Chan AW; Bedding A; Stephens R; Richards D; Roberts L; Kirkpatrick J; de Bono J; Yap C
    BMC Med; 2023 Jul; 21(1):246. PubMed ID: 37408015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPIRIT 2013 statement: defining standard protocol items for clinical trials.
    Chan AW; Tetzlaff JM; Altman DG; Laupacis A; Gøtzsche PC; Krleža-Jerić K; Hróbjartsson A; Mann H; Dickersin K; Berlin JA; Doré CJ; Parulekar WR; Summerskill WS; Groves T; Schulz KF; Sox HC; Rockhold FW; Rennie D; Moher D
    Ann Intern Med; 2013 Feb; 158(3):200-7. PubMed ID: 23295957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
    Chan AW; Tetzlaff JM; Gøtzsche PC; Altman DG; Mann H; Berlin JA; Dickersin K; Hróbjartsson A; Schulz KF; Parulekar WR; Krleza-Jeric K; Laupacis A; Moher D
    BMJ; 2013 Jan; 346():e7586. PubMed ID: 23303884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.
    Tunn R; Boutron I; Chan AW; Collins GS; Hróbjartsson A; Moher D; Schulz KF; de Beyer JA; Hansen Nejstgaard C; Østengaard L; Hopewell S
    J Clin Epidemiol; 2024 May; 169():111309. PubMed ID: 38428538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.